PE
ASMB icon

Point72 Europe’s Assembly Biosciences ASMB Stock Holding History

Point72 Europe’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$332 Buy
+13
New +$285 ﹤0.01% 715

Other funds holding ASMB

GS
Gilead Sciences Foster City, California $2.12B AUM 143.53% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Point72 Europe's ASMB Position: Q3 2025 in Review

Point72 Europe opened a new position in Assembly Biosciences (ASMB) in Q3 2025: 13 shares worth $332. The stake represents ﹤0.01% of the portfolio and ranks #715 among its holdings.

57 funds tracked by Wall St. Rank hold ASMB as of Q3 2025.

  • Point72 Europe held 13 shares of Assembly Biosciences worth $332 as of Q3 2025.
  • Assembly Biosciences was a new Point72 Europe position in Q3 2025.
  • Assembly Biosciences made up ﹤0.01% of Point72 Europe's portfolio in Q3 2025, its #715 holding.
  • 57 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2025.

Based on Point72 Europe's 13F filing for Q3 2025, filed 14 Nov 2025.